Specialty Tax Incentives in the Life Sciences:

Part II: R&D Tax Credits 

September 6, 2024

The cost per square foot associated with equipping a life sciences property is higher than that associated with fitting out any other type of commercial real estate.  

Specialty tax incentives are an excellent way to offset the large capital expenditures involved in equipping and maintaining life science facilities.  

We’ve already discussed how life science companies can benefit from real estate-based incentives like Cost Segregation and the 179D Deduction. Now we’ll turn our focus to the R&D Tax Credit.  

INTRODUCTION 

The government recognizes the capital-intensive nature of the biotechnology industry. The development of sophisticated, potentially life-saving solutions requires a tremendous investment, over an extended period of time. The R&D Tax Credit was created to help offset the large capital expenditures that challenge many firms, especially in their early years of operation.  

CREDIT BENEFITS 

  • The Federal Credit can add up quickly, offering up to 10 cents in benefit for every qualifying dollar identified.  Plus, up to 40 states offer their own versions, further boosting cash flow.   
  • The Credit can be taken annually – if your firm continues to meet eligibility criteria, it can become a renewable source of revenue you can rely on. This is particularly helpful in the biotech industry, where projects may easily span 10-15 years.   
  • Unfortunately, there is inherent risk in this industry. Many drugs and drug devices never see the light of day. One silver lining? Unsuccessful research can qualify for R&D Tax Credit as well. 

CREDIT ELIGIBILITY 

The R&D Tax Credit is an activities-based Credit, and virtually all life science firms qualify for the R&D Tax Credit just by performing their day-to-day activities.  

To officially be considered a Qualified Research Activity (QRA), your activity must pass the IRS’ Four-Part Test. This is generally a very easy task in the life sciences:  

PART I: New or Improved Business Component: The activity must be related to developing or improving the functionality, quality, reliability, or performance of a business component.  

In the life sciences, the business component may be a drug, medical device or biologic, or may be the process by which the product is made.  

PART II: Elimination of Uncertainty: The activity must be undertaken for the purpose of eliminating some uncertainty —  

  • Can I make a brand-new product? 
  • What will the new product design look like? How can I make it? 
  • Can I improve an old product? Is this even feasible? 
  • Can I improve the process by which the product is made? 
  • How can I incorporate new features and functions into an existing product/process?  

Questions like these are the lifeblood of the life sciences.   

PART III: Process of Experimentation: The activity must involve some kind of experimentation designed to resolve the uncertainty, which may include:  

  • Evaluation of Alternatives 
  • Hypothesis Testing 
  • Systematic Trial and Error 
  • 3D Modeling or Simulations  

Life science professionals engage in these activities daily.   

PART IV: Technological in Nature: The activity must be based on a hard science – biology, chemistry, pharmaceutics, etc.  

Clearly, these hard sciences are the core of the biotech world.   

QUALIFIED ACTIVITIES AND EXPENSES  

Qualified activities could involve the creation or optimization of any of the following:  

  • Drugs, medical devices, and biologics
  • Drug delivery systems
  • Diagnostics, assays, reagents, species/strands
  • Formulations 
  • Animal-tissue testing 
  • Non-clinical testing including efficacy, toxicity, and pharmacokinetics 
  • Clinical testing prior to commercialization 
  • Manufacturing processes
  • Quality assurance testing to ensure that products meet FDA and industry standards
  • Software development for analytical, scientific, or computational purposes 

Efforts to improve the shelf life, side-effect profile, efficacy, and reliability of a product are also qualified activities.  

Qualified Research Expenses (QREs) are expenses related to QRAs. QREs are the expenses that can qualify for the Credit, and they fall into 4 categories:  

  • Supplies and Materials 
  • Employee Wages 
  • Third-Party Contractor Payments 
  • Cloud Hosting Expenses   

CLAIMING AND DOCUMENTING THE CREDIT  

The R&D Credit is claimed by filing IRS Form 6765, Credit for Increasing Research Activities. Taxpayers must provide “sufficient documentation” to support the amount of QREs they are claiming.  

The IRS does not specify what constitutes “sufficient documentation.” In general, the more documentation you can retain and provide as needed, the better. Examples include:  

  • Payroll information for employees directly involved in R&D and for employees or managers supervising them 
  • General ledger reports indicating which costs and supplies were related to R&D activities 
  • Copies of contracts and invoices paid to third-party contractors 
  • General documents that demonstrate the research process and progress: experimental protocols, results, conclusions, technical uncertainties and efforts taken to resolve them, along with relevant emails, presentations, or meeting minutes  

Credible employee testimony is also helpful in substantiating the R&D Tax Credit claim, especially in conjunction with documentation.  

In the life sciences, regulatory authorities require that each phase of the discovery process be meticulously documented. This copious recordkeeping also provides excellent support for an R&D Tax Credit claim.  

A thoroughly documented Credit translates into meaningful tax savings. Consider ABC Bioventures, a $3.5M firm.  

They conduct rigorous prototyping and testing for personalized post-operative protocols.  

ABC Bioventures documented:  

  • $1.5M in wages, $1M of which qualified under the Credit  
  • $1M in supplies, $500K of which qualified under the Credit  
  • $50K in payments to third-party contractors, all of which qualified under the Credit    

The above expenditures translated into a $160,000 Federal and State R&D Tax Credit for ABC Bioventures.  

What About Biotech or Biopharma Start-Ups? 

The Payroll R&D Tax Credit is a modified version of the Federal R&D Tax Credit, created specifically for small businesses that do not yet have income tax liability.  

The Payroll R&D Tax Credit permits “Qualified Small Businesses” (QSBs) to claim up to $500,000 annually for tax years beginning after December 31, 2022. QSBs can use that credit to offset the 6.2% employer portion of the Social Security payroll tax under the Federal Insurance Contributions Act (FICA) as well as the 1.45% employer portion of the Medicare payroll tax liability ($250,000 towards each).  

(For tax years prior to December 31, 2022, the maximum claim is $250,000, and the credit only applies to the social security tax.)   

The Payroll R&D Tax Credit can be taken for up to 5 years, resulting in a potential total credit of $2.5M to apply against payroll taxes. This is a huge boon to biotech start-ups, freeing up the crucial capital needed to grow.  

To be considered a “Qualified Small Business,” you must:  

  • Have less than $5M in gross receipts for the year in which you wish to claim the credit; and  
  • Never have had gross receipts five years prior to the claim year 

What About Sec. 174 Amortization?  

Section 174 Expenses are known as Research and Experimentation, or R&E Expenses. They include Direct Research Expenses that qualify for the R&D Tax Credit and Indirect Research Expenses that are generally more incidental costs.   

Sec. 174 Expenses incurred in Tax Year 2022 and beyond can no longer be immediately deducted, but must instead be amortized over 5 years. The impact of this is primarily a timing issue.   

By amortizing the deduction over 5 years, taxpayers will see a higher net taxable income initially. Generally, taxpayers will pay more taxes in year 1 and year 2, but not more overall. In fact, most taxpayers will “break even” by year 3 and pay little to no tax in that year and beyond. Smaller firms and start-ups will likely feel the impact of the increased tax liability more deeply, even if it is only short-term.  

However, this is not a reason to avoid claiming the R&D Tax Credit:  

  • The R&D Tax Credit will actually help mitigate the effects of mandatory amortization  
  • Skipping a year of the R&D Tax Credit won’t let you “skip” Sec. 174 amortization. The R&D Tax Credit doesn’t create Sec. 174 Expenses – if you have them, you have them, and they must be amortized whether you claim the R&D Tax Credit or not. 
  • Plus, if you consistently claimed the R&D Tax Credit and suddenly don’t, that may attract unwanted IRS attention.  

Sec. 174 amortization is an important matter to discuss with your taxation expert, but it’s not a reason to avoid the R&D Tax Credit.   

TAKEAWAYS 

  • Virtually every life science firm is eligible for the R&D Tax Credit, which can be a reliable source of revenue to offset a firm’s capital-heavy burden 
  • Larger firms can benefit from the standard credit, claiming up to $0.10 on every identified dollar, while start-ups can access the Payroll Version of the Credit
  • The recordkeeping requirements of the life science industry also provide the necessary documentation required to successfully claim the R&D Credit
  • Over 3 dozen states have their own versions of the Credit that may be claimed in tandem with the Federal Credit 

From bench to bedside, you’re pushing the boundaries of what’s possible. So much is at stake in this important work – it’s crucial to ensure that you are fully leveraging the power of specialty tax incentives.  

Sign Up for Our Monthly Newsletter!

How To claim the R&D tax Credit
Determine R&D Tax Credit Eligibility - four part test

“

The cost per square foot associated with equipping a life sciences property is higher than that associated with fitting out any other type of commercial real estate.  

Recent Articles

Predominant Use Studies: Your Top 10 Questions Answered

Predominant Use Studies: Your Top 10 Questions Answered

Predominant Use Studies: Your Top 10 Questions Answered Utility costs are a significant operating expense for many businesses. But what if part of your utility bill is an expense you shouldn’t be paying at all?  In many states, electricity, natural gas, and certain...

Look-Back Cost Segregation Studies for Rental Properties

Look-Back Cost Segregation Studies for Rental Properties

Look-Back Cost Segregation Studies for Rental PropertiesMany rental property owners file their taxes every year without really thinking about depreciation. The building gets depreciated over decades, and no one asks any questions.    The problem? Your property isn't...

Cost Segregation Tax Benefits

Cost Segregation Tax Benefits

Cost Segregation Tax Benefits How a Cost Segregation Study Can Reduce Taxes and Improve Cash Flow  Real estate owners often think of a building as one large depreciable asset. For tax purposes, however, a property can contain many different components with different...